Comprehensive GCC nursing reference covering health promotion theories, screening programmes, chronic disease prevention, immunisation, patient education and exam preparation.
GCC Clinical Reference | Evidence-Based | 2024The foundational WHO document defining health promotion. Defines health promotion as "the process of enabling people to increase control over, and to improve, their health."
Health on the agenda of all policy-makers. Legislation, fiscal measures, taxation, organisational change. Example: tobacco taxation, food labelling laws, urban green spaces.
Work, leisure, home and community settings. Safe, stimulating, satisfying environments. GCC example: air-conditioned walking tracks, smoke-free public spaces.
Concrete, effective community action — setting priorities, making decisions, planning and implementing strategies. Community empowerment and participation.
Support personal and social development through health information, education for health and enhancing life skills. Enables individuals to make healthier choices.
Health sector responsibility shifts beyond clinical and curative services toward health promotion. Cross-sectoral collaboration. Sensitivity to cultural needs. GCC relevance: integrating prevention into PHC visits.
Canadian government report "A New Perspective on the Health of Canadians." Identified four determinants of health — healthcare organisation accounts for only ~10% of population health.
Genetics, maturation and ageing, complex internal systems. Haemoglobinopathies prevalent in GCC populations (sickle cell, thalassaemia) represent biological determinants.
Physical, social, cultural environment. Air quality, water, food safety, social cohesion. GCC: extreme heat, indoor air quality, rapid urbanisation.
Personal decisions — smoking, physical inactivity, diet, alcohol, drug use. Largest single determinant. Primary focus of health promotion interventions.
Availability, quality and relationships among healthcare services. Paradox: highest spending often in this determinant despite smallest population health impact.
Layered model showing interaction of individual factors through broader social determinants. Informs health equity approaches.
| Layer | Examples | GCC Context |
|---|---|---|
| Core: Individual | Age, sex, genetic factors | Consanguinity rates in GCC, genetic disease burden |
| Individual lifestyle | Diet, exercise, smoking | High obesity, low PA, shisha smoking prevalence |
| Social & community networks | Social support, norms | Extended family networks — strong health resource |
| Living & working conditions | Housing, employment, food access | Migrant worker health disparities, occupational heat stress |
| General socioeconomic/cultural | GDP, education, urbanisation | Rapid wealth growth, food environment, media influence |
Not thinking about change. "Problem? What problem?"
Aware of problem, considering change within 6 months.
Intends to take action within 30 days. Planning stage.
Actively modifying behaviour. High effort required.
>6 months sustained change. Relapse prevention focus.
Attitude (positive/negative evaluation) + Subjective Norms (perceived social pressure) + Perceived Behavioural Control (perceived ease/difficulty) → Intention → Behaviour
GCC relevance: Subjective norms (family/community expectations) particularly strong predictors in collectivist cultures. Spouse and family attitudes strongly predict screening uptake in women.
A collaborative, person-centred counselling style to elicit and strengthen motivation for change. Evidence-based for smoking cessation, diabetes self-management, weight loss, substance misuse.
"What concerns do you have about your weight?" — Invites elaboration, avoids yes/no answers.
Genuine statements recognising strengths: "You've managed to reduce your smoking despite a stressful time — that takes real determination."
Simple reflection (repeats/rephrases), Complex reflection (adds meaning/emotion). "It sounds like you feel frustrated that previous attempts haven't worked."
Collects change talk, transitions, links patient's values to change. Bouquet of flowers analogy — gather and present back.
| Level | Definition | Examples | GCC Examples |
|---|---|---|---|
| Primary Prevention | Prevent disease onset in healthy individuals | Vaccination, health education, water fluoridation, tobacco legislation | National immunisation programmes, school health, smoke-free laws |
| Secondary Prevention | Early detection before symptoms (screening) | Cervical smear, mammography, BP measurement, HbA1c in high-risk | Premarital screening, diabetic retinopathy screening, newborn heel-prick |
| Tertiary Prevention | Reduce impact and complications of established disease | Cardiac rehab, diabetes foot care, stroke rehabilitation | Chronic disease management programmes in PHC, HAAD/MOH chronic care models |
| Quaternary Prevention | Protect from harms of excessive medical intervention (Marc Jamoulle) | Avoiding unnecessary investigations, polypharmacy review, overdiagnosis awareness | Emerging concept; antibiotic stewardship, avoiding unnecessary caesarean sections |
A screening programme should satisfy all 10 criteria before implementation.
Performed at 48–72 hours of life. Panel varies by country but typically includes: PKU (phenylketonuria), congenital hypothyroidism, sickle cell disease, G6PD deficiency, CAH (congenital adrenal hyperplasia), galactosaemia, and expanded metabolic panel.
GCC priority: G6PD deficiency and haemoglobinopathies have significantly higher prevalence than global averages. Saudi Arabia: expanded newborn screening panel includes 25+ conditions.
Mandatory in Saudi Arabia, UAE, Qatar, Kuwait. Typically includes:
Aim: genetic counselling, prevention of transmission of communicable diseases. Results disclosed to both parties.
Developing across GCC. HPV prevalence in GCC lower than Western countries due to cultural and legal factors. Programmes: Pap smear (cytology — 3-yearly from 25) and increasingly HPV primary testing (5-yearly from 25–30). UAE: structured programmes within DHA/DOH frameworks. Cultural barriers: stigma, access to female providers, lack of awareness.
Mammography (2-yearly, 40–74 years). UAE: most formalised programme in GCC — Pink Caravan, national breast cancer screening. Saudi: ad hoc, being formalised under Vision 2030. GCC breast cancer: presents at younger age and more advanced stage than Western populations — awareness critical. Clinical breast examination as adjunct.
Programmes developing across GCC. Options: Faecal Occult Blood Test (FOBT)/FIT (annually or biannually), colonoscopy (10-yearly), flexible sigmoidoscopy. Start at 50 years (45 in some guidelines). Risk factors: high red meat, low fibre diet, family history, obesity, IBD.
Annual dilated fundal examination for all patients with type 1 or type 2 diabetes. GCC priority given world's highest diabetes prevalence. Digital retinal photography increasingly used. Prevents blindness — leading cause of preventable blindness in working-age adults.
| Test | Target | Frequency | Action Threshold |
|---|---|---|---|
| Blood Pressure | All adults ≥18 | Every 1–5 years | ≥140/90 mmHg: lifestyle + consider treatment |
| Fasting Glucose / HbA1c | Overweight, risk factors | 3-yearly if normal | HbA1c ≥48 mmol/mol = diabetes; 42–47 = prediabetes |
| BMI / Waist Circumference | All adults | Each visit | BMI ≥25 overweight; ≥30 obese. Waist M>94cm/F>80cm |
| Fasting Lipid Profile | CVD risk, diabetes, family hx | 5-yearly if normal | Total cholesterol >5.0; LDL >3.0; HDL <1.0 |
| PSA (Prostate) | Males ≥50 (shared decision) | Controversial | Discuss benefits/harms; no population programme |
Leading cause of death across GCC. Premature CVD (under 65) significantly higher than global average. Saudi Arabia CVD mortality: ~45% of all deaths.
Kuwait, Qatar, Saudi Arabia among world's highest prevalence (18–25%). Combination of genetic susceptibility, obesity, sedentary lifestyle, dietary patterns.
Adult obesity prevalence: Kuwait 37.9%, Qatar 35.1%, Saudi Arabia 34.7%, UAE 31.7%. Driven by high-calorie diet, car-dependency, indoor lifestyle from heat.
Highly prevalent — often undiagnosed. Salt-rich diet (processed food, fast food culture), obesity, physical inactivity are primary drivers.
| Step | Action |
|---|---|
| Ask | Identify and document smoking status for every patient |
| Advise | Strong, clear, personalised advice to quit ("Quitting is the single most important thing you can do for your health") |
| Assess | Assess willingness to quit — TTM stage |
| Assist | Set quit date, NRT, prescribe pharmacotherapy, provide self-help material |
| Arrange | Follow-up contact within 1 week of quit date |
Patch, gum, lozenge, inhaler, nasal spray. First-line, safe in most patients. Combination NRT (patch + fast-acting) superior to monotherapy. Available OTC in GCC.
Partial nicotinic receptor agonist. Most effective single pharmacotherapy. 12-week course. Monitor neuropsychiatric side effects. Prescription only.
Antidepressant with NRT mechanism. Second-line. Caution: seizure threshold, interactions. 7–12 week course. Prescription only.
Combining NRT + varenicline or NRT + bupropion + counselling = highest quit rates. Behavioural support doubles pharmacotherapy success rates.
| Component | Description | Example Prescription |
|---|---|---|
| Frequency | How often per week | 5 days/week (moderate); 3 days/week (vigorous) |
| Intensity | Moderate (60–70% HRmax) / Vigorous (70–85% HRmax) | Talk test: moderate = can talk, vigorous = difficulty talking |
| Time | Duration per session | 30 min moderate/day (can be 3 × 10 min bouts) |
| Type | Aerobic, resistance, flexibility, balance | Walking, swimming, cycling, resistance bands |
| Tool | Population | Predicts | Treatment Threshold |
|---|---|---|---|
| QRISK3 | UK/European — validated across ethnicities | 10-year CVD risk (%) | ≥10%: consider statin (NICE NG238) |
| Framingham Risk Score | US general population | 10-year coronary heart disease risk | ≥10% moderate; ≥20% high |
| ACC/AHA ASCVD Pooled Cohort | US guidelines | 10-year ASCVD risk | ≥10%: statin therapy (ACC/AHA 2019) |
| Age | Vaccines | Notes |
|---|---|---|
| Birth | HBV (1st dose), BCG | BCG given in countries with moderate-high TB burden. HBV within 24h of birth. |
| 2 months | DTaP-IPV-Hib-HBV (pentavalent/hexavalent), PCV13, Rotavirus (RV1) | Rotavirus oral. PCV protects against pneumococcal disease. |
| 4 months | DTaP-IPV-Hib, PCV13, Rotavirus | 2nd doses |
| 6 months | DTaP-IPV-Hib-HBV, PCV13, Rotavirus (RV5), Influenza (annual) | HBV 3rd dose. Annual influenza from 6 months. |
| 12–15 months | MMR (1st), Varicella (1st), PCV booster, MenC/MenACWY | MMR minimum 12 months. Varicella may be combined (MMRV). |
| 18 months | DTaP booster, IPV, Hib booster | 4th DTaP. Check local schedule — varies by GCC state. |
| 4–6 years | DTaP booster, IPV booster, MMR 2nd | School entry booster. MMR 2nd dose ensures 97%+ protection. |
| 11–14 years | Td/Tdap booster, HPV (2 doses 6–12 months apart) | HPV: females universally; males included in UAE, Qatar, Saudi. 9-valent HPV preferred. |
| Adults (annual) | Influenza | All adults, especially pregnant, elderly, chronic disease, HCW. |
| Adults ≥60 | Herpes Zoster (Shingrix — 2 doses), Pneumococcal (PCV20 or PPSV23) | Pneumococcal also for chronic disease, immunocompromised, asplenia. |
| Vaccine | Requirement | Notes |
|---|---|---|
| Hepatitis B (HBV) | Mandatory — 3-dose series | Check seroconversion: anti-HBs titre ≥10 IU/L 1–2 months post-series. Non-responders: 2nd series then HBIG if exposure. |
| Influenza | Annual — highly recommended/mandatory in most GCC hospitals | Protects patients. HCW influenza vaccination associated with reduced patient mortality. |
| MMR | 2 documented doses or serology-confirmed immunity | Born after 1957. Check mumps, measles, rubella titres if uncertain. |
| Varicella | 2 doses or documented disease/serology | VZV IgG confirms immunity. Risk of severe disease and transmission to immunocompromised patients. |
| COVID-19 | Initial series + boosters per national guidance | Requirements vary; most GCC health systems mandatory for HCW. |
| Tdap | One-time Tdap replacing Td booster; then Td every 10 years | Especially important for HCWs in contact with neonates (cocoon strategy). |
Ability to read and follow basic health instructions — medicine labels, appointment cards.
Ability to extract and apply health information in different contexts — adapting advice to daily life.
Ability to critically evaluate and use health information — assessing reliability of internet sources, shared decision-making.
"I want to make sure I explained this clearly — can you tell me in your own words what you will do when you get home?"
"What will you do if you notice [warning sign]?"
"Just to check I've done a good job explaining — can you show me how you would take this medication?"
"On a scale of 0–10, how important is it to you to change [behaviour]?"
If score is 5: "Why did you choose 5 and not 3?" (elicits change talk)
"On a scale of 0–10, how confident are you that you could change [behaviour] if you decided to?"
If low: explore barriers, problem-solve, build self-efficacy
| Stage | Description | Nurse Role |
|---|---|---|
| Team Talk | Establish that decisions involve a choice; convey support | "There are options here and your preferences matter — we'll work through this together." |
| Option Talk | Explain all reasonable options with their attributes | Use decision aids, comparative risk information, patient-friendly formats |
| Decision Talk | Elicit patient's preferences, integrate with evidence, reach decision | Confirm patient's preferred option, check understanding, document discussion |
What are the benefits of this treatment/procedure?
What are the risks and side effects?
What other options are available?
What happens if I do nothing / wait and see?
1. A nurse is assessing a patient using the Health Belief Model. The patient states: "I don't think I'm at risk of diabetes." Which component of the HBM does this represent?
A. Perceived severity B. Perceived susceptibility C. Perceived barriers D. Self-efficacy2. According to the Transtheoretical Model, a patient says "I've been thinking about quitting smoking for the past few months but haven't done anything yet." Which stage is this patient in?
A. Pre-contemplation B. Preparation C. Contemplation D. Action3. Which of the following is a mandatory component of premarital screening across most GCC countries?
A. PSA (prostate-specific antigen) B. Cervical cytology (Pap smear) C. Haemoglobin electrophoresis (sickle cell/thalassaemia) D. Colonoscopy4. A nurse is teaching about the Ottawa Charter. Which action area best describes establishing laws limiting tobacco advertising?
A. Developing personal skills B. Reorienting health services C. Building healthy public policy D. Creating supportive environments5. A patient smokes 1 hour of shisha daily. When counselling them, which statement is most accurate regarding shisha versus cigarette exposure?
A. Shisha is safer because the water filters out harmful substances B. 1 hour shisha session is equivalent to approximately 100–200 cigarettes in tar exposure C. Shisha contains no nicotine D. Shisha has no association with cardiovascular disease6. During a motivational interviewing session, a patient says: "I know I should exercise but I really don't have time." The nurse responds: "It sounds like time is the main obstacle for you right now." This is an example of which OARS skill?
A. Open questioning B. Affirmation C. Reflective listening D. Summarising7. A healthcare worker received the hepatitis B vaccination series 6 weeks ago. What is the appropriate post-vaccination action?
A. No further action required — immunity is guaranteed B. Repeat the full 3-dose series immediately C. Check anti-HBs titre — response confirmed if ≥10 IU/L D. Administer HBIG as routine post-vaccination protocol8. Which prevention level does annual diabetic retinopathy screening represent?
A. Primary prevention B. Secondary prevention C. Tertiary prevention D. Quaternary prevention9. When teaching using the teach-back method, which statement best reflects the correct approach?
A. "Did you understand everything I just told you?" B. "Can you repeat back to me exactly what I said?" C. "I want to make sure I explained this clearly — can you tell me in your own words what you will do at home?" D. "You clearly understand — you nodded throughout the session."10. A Saudi national patient with type 2 diabetes declines lifestyle change advice, stating "Everything is God's will — my health is in His hands." Which approach is MOST culturally appropriate?
A. Emphasise personal responsibility and autonomy as primary motivators B. Acknowledge their belief, then frame health care as fulfilling the Islamic concept of amanah (trusteeship of the body) C. Escalate to the GP immediately as the patient is refusing care D. Provide only written materials and end the consultationEnter patient details to identify modifiable CVD risk factors and generate evidence-based, GCC-adapted lifestyle advice. This tool is educational and does not replace formal risk calculators (QRISK3, Framingham) or clinical judgment.